Intrinsic and extrinsic apoptosis responses in leukaemia cells following daunorubicin treatment

Daunorubicin is used clinically in the treatment of myeloma, acute lymphatic and myelocytic leukaemia. The toxic lesions caused by daunorubicin induce various modes of cell death, including apoptosis. Apoptosi...

Source: BMC Cancer - April 21, 2021 Category: Cancer & Oncology Authors: Hussain Mubarak Al-Aamri, Helen R. Irving, Christopher Bradley and Terri Meehan-Andrews Tags: Research Source Type: research